Status:
COMPLETED
Same-session MR-only Simulation and Treatment With MRI-guided Adaptive Palliative RadioTherapy
Lead Sponsor:
Washington University School of Medicine
Conditions:
Malignancy
Metastasis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This proposed study is unique in that patients will not undergo computed tomography (CT) simulation at any point during their treatment course and will instead have same-session magnetic resonance (MR...
Eligibility Criteria
Inclusion
- Diagnosis of malignancy (biopsy proven or high clinical suspicion with urgent/emergent clinical indications for palliative RT)
- Requires delivery of palliative radiation therapy for the treatment of painful metastasis, hemoptysis, gastrointestinal bleeding, pelvic bleeding, or superior vena cava syndrome/bulky mediastinal disease.
- At least 18 years of age.
- Able to understand and willing to sign an IRB-approved written informed consent document.
Exclusion
- Pregnant. Patients of childbearing potential must have a negative pregnancy test within 14 days of study entry.
- Medical contraindication to undergoing MR imaging.
Key Trial Info
Start Date :
April 23 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 14 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03824366
Start Date
April 23 2019
End Date
January 14 2022
Last Update
January 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110